Alan Dove

1.3k total citations
114 papers, 968 citations indexed

About

Alan Dove is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Reproductive Medicine. According to data from OpenAlex, Alan Dove has authored 114 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 23 papers in Public Health, Environmental and Occupational Health and 12 papers in Reproductive Medicine. Recurrent topics in Alan Dove's work include Biotechnology and Related Fields (13 papers), Science, Research, and Medicine (12 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alan Dove is often cited by papers focused on Biotechnology and Related Fields (13 papers), Science, Research, and Medicine (12 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Alan Dove collaborates with scholars based in United States, United Kingdom and China. Alan Dove's co-authors include Kelly A. Martin, Andrew Marshall, John Hodgson, Laura Bonetta, Myrna E. Watanabe, Jiao Wang, Weili Xu, Weizhong Yang, Xiuying Qi and David A. Bennett and has published in prestigious journals such as Science, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Alan Dove

92 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Dove United States 13 548 122 104 87 80 114 968
Markus Schneider Germany 18 801 1.5× 119 1.0× 75 0.7× 123 1.4× 86 1.1× 56 1.4k
Margot G. Paulick United States 12 784 1.4× 118 1.0× 275 2.6× 91 1.0× 78 1.0× 14 1.1k
Aris Persidis United States 17 513 0.9× 203 1.7× 72 0.7× 41 0.5× 36 0.5× 52 1.0k
Xuefei Li China 19 759 1.4× 120 1.0× 90 0.9× 60 0.7× 40 0.5× 53 1.2k
Melissa M. Kemp United States 19 850 1.6× 230 1.9× 186 1.8× 56 0.6× 22 0.3× 21 1.5k
L Pagliaro United States 14 662 1.2× 228 1.9× 60 0.6× 81 0.9× 22 0.3× 31 1.2k
Martin J. Valler Germany 17 660 1.2× 64 0.5× 71 0.7× 61 0.7× 42 0.5× 25 1.0k
William G. Turnell United Kingdom 15 838 1.5× 41 0.3× 114 1.1× 170 2.0× 48 0.6× 20 1.3k
Laura E. Sanman United States 11 615 1.1× 153 1.3× 173 1.7× 119 1.4× 35 0.4× 16 987

Countries citing papers authored by Alan Dove

Since Specialization
Citations

This map shows the geographic impact of Alan Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Dove more than expected).

Fields of papers citing papers by Alan Dove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Dove. The network helps show where Alan Dove may publish in the future.

Co-authorship network of co-authors of Alan Dove

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Dove. A scholar is included among the top collaborators of Alan Dove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Dove. Alan Dove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jing, Henry D. Huang, Yang Wang, et al.. (2024). Association between Resting Heart Rate and Machine Learning-Based Brain Age in Middle- and Older-Age. The Journal of Prevention of Alzheimer s Disease. 11(4). 1140–1147. 2 indexed citations
2.
Yang, Weizhong, Jiao Wang, Jìng Guo, et al.. (2024). Association of Cognitive Reserve Indicator with Cognitive Decline and Structural Brain Differences in Middle and Older Age: Findings from the UK Biobank. The Journal of Prevention of Alzheimer s Disease. 11(3). 739–748. 8 indexed citations
3.
Li, Peng, Wanju Yang, Jian Wang, et al.. (2024). Association between Cognitive Reserve Indicator and Chronic Disease-Free Survival: A Large Community-Based Longitudinal Study. The Journal of Prevention of Alzheimer s Disease. 11(6). 1712–1720.
4.
Dove, Alan. (2009). Coast IRB hits treacherous waters. Nature Medicine. 15(5). 470–470. 2 indexed citations
5.
Dove, Alan. (2009). Epigenetics: The Final Frontier?. Science. 326(5950). 303–303. 3 indexed citations
6.
Dove, Alan. (2005). New rules propose greater scrutiny for NIH grant recipients. Nature Medicine. 12(1). 5–5. 1 indexed citations
7.
Dove, Alan. (2003). Screening for content—the evolution of high throughput. Nature Biotechnology. 21(8). 859–864. 50 indexed citations
8.
Dove, Alan. (2002). It takes a village to raise an idiot: fixing US science education. Journal of Clinical Investigation. 110(8). 1057–1060. 2 indexed citations
9.
Dove, Alan. (2002). It takes a village to raise an idiot: fixing US science education. Journal of Clinical Investigation. 110(8). 1057–1060. 2 indexed citations
10.
Dove, Alan. (2002). Biomarker database may yield blockbuster drug. Nature Medicine. 8(10). 1049–1050. 1 indexed citations
11.
Dove, Alan. (2002). Promising drug is victim of bad business. Nature Medicine. 8(3). 199–199. 3 indexed citations
12.
Dove, Alan. (2002). FDA lowers the bar for biodefense drugs. Nature Medicine. 8(7). 646–646. 1 indexed citations
13.
Dove, Alan. (2002). When science rides the MTA. Journal of Clinical Investigation. 110(4). 425–427. 1 indexed citations
14.
Dove, Alan. (2001). Proteomics: Basic research climbs aboard. Nature Medicine. 7(9). 984–984. 1 indexed citations
15.
Dove, Alan. (2000). NIH ‘glues’ cell biologists together. Nature Medicine. 6(10). 1072–1072. 1 indexed citations
16.
Dove, Alan. (1999). Leptin efficacy looks slim. Nature Biotechnology. 17(12). 1147–1147. 1 indexed citations
17.
Dove, Alan. (1999). Drug screening—beyond the bottleneck. Nature Biotechnology. 17(9). 859–863. 72 indexed citations
18.
Dove, Alan. (1998). Pulling green biotechnology out of the red. Nature Biotechnology. 16(11). 1022–1024. 1 indexed citations
19.
Dove, Alan, et al.. (1985). How dangerous is sledging?. BMJ. 290(6471). 821–821. 8 indexed citations
20.
Dove, Alan, et al.. (1975). Haemolytic anaemia due to penicillin.. BMJ. 3(5985). 684.1–684. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Schneider Breakdown of academic impact, for papers by Margot G. Paulick Breakdown of academic impact, for papers by Aris Persidis Breakdown of academic impact, for papers by Xuefei Li Breakdown of academic impact, for papers by Melissa M. Kemp Breakdown of academic impact, for papers by L Pagliaro Breakdown of academic impact, for papers by Martin J. Valler Breakdown of academic impact, for papers by William G. Turnell Breakdown of academic impact, for papers by Laura E. Sanman
Rankless by CCL
2026